Oncology CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Patient Stories From the HCC CaseBook: Expert Guidance on Optimizing Outcomes and Care With Newly Available and Emerging Therapies
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Transforming Modern Care in AML: Clinical Solutions With Novel Agents for Diverse Patient Populations
July 10, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Harnessing the Immune System in the Treatment of TNBC and Beyond: Where Are We Now and Where Are We Going Next?
July 9, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Up Close and Personalizing Gastric Cancer Care: Precision Medicine With HER2-Targeted Therapies and Other Novel Agents
July 8, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape
July 8, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
June 30, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence
June 22, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Innovative Treatments for Bladder Cancer: Thoughts From the Chair
June 22, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
June 18, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Finding the Path to Clinically Meaningful Outcomes Among Expanding Treatment Options in Renal Cell Carcinoma
June 18, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Agent Sequencing Across the Treatment Continuum
June 17, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: HER2-Targeted and Other Agents for Gastric Cancer
June 17, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Fueling Innovation in Multiple Myeloma: Thoughts From the Chair
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Advances in AML Care: Highlights From Recent Science
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take: Review of the Latest HCC Therapy Advancements
June 12, 2020
Credits: 0.50 CME / MOC / CPE
Medical Learning Institute, Inc.
Chair’s Take on Cancer-Associated VTE: Highlights From Recent Science
June 11, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Targeting Pathogenic Mutations in the DNA Damage Response Pathway: Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing
May 27, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer
April 30, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Purdue University
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care
April 28, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Changing Perspectives on Multiple Myeloma and ASCT: Clinical Decision-Making, New Evidence, and Expanding Therapeutic Options
March 31, 2020

Pages